181/465US=23-E / Câncer
Quan JR WDY, Quan FM. Metastatic kidney cancer: treatment with infusional interleukin-2 plus famotidine. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 115-20. ISBN 978-90-481-2917-1.

CANCER RENAL METASTATICO; TRATAMENTO COM INFUSAO DE INTERLEUCINA-2

182/465US=23-E / Câncer
Klatte T, Böhm M. Renal cell carcinoma: preoperative treatment with cytokines followed by surgery. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 121-35. ISBN 978-90-481-2917-1.

CARCINOMA DE CELULAS RENAIS; TRATAMENTO PRE-OPERATORIO COM CITOCINAS

183/465US=23-E / Câncer
Tomita Y, Maruyama R, Itoi T, Bilim V. Metastatic renal cell carcinoma: use of Bcl-2 and Fas to predict responses to immunotherapy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 137-45. ISBN 978-90-481-2917-1.

CARCINOMA; METASTATICO DE CELULAS RENAIS; BCL-2 E FAS; IMUNOTERAPIA

184/465US=23-E / Câncer
Ozluk Y. Wilms tumor: prognosis using microvessel density. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 147-55. ISBN 978-90-481-2917-1.

TUMOR DE WILMS; DENSIDADE MICROVASCULAR. PROGNOSTICO; ANGIOGENESE

185/465US=23-E / Câncer
Burel-Vandenbos F, Cardot-Leccia N, Haudebourg J, Ambrosetti D, Michiels JF. Adenomatoid tumor of the adrenal gland: differential diagnosis using immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 161-65. ISBN 978-90-481-2917-1.

TUMOR ADENOMATOIDE DA GLANDULA SUPRA-RENAL; DIAGNOSTICO COM IMUNOISTOQUIMICA; IMUNOFENOTIPO

186/465US=23-E / Câncer
Spiess PE, Tannir NM, Pisters LL. Testicular cancer: post-chemotherapy retroperitoneal lymph node dissection. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 167-79. ISBN 978-90-481-2917-1.

CANCER DE TESTICULO; POS-QUIMIOTERAPIA; RETROPERITONEAL DISSECCAO DE LINFONODOS

187/465US=23-E / Câncer
Richiardi L, Maule MM. Survivors of germ-cell testicular cancer: increased risk of second primary tumors. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 181-91. ISBN 978-90-481-2917-1.

GERMES; CELULAS DE CANCER TESTICULAR; TUMOR PRIMARIO

188/465US=23-E / Câncer
Svatek RS, Lotan Y. Urothelial bladder cancer: screening with urine-based tumor markers. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 197-209. ISBN 978-90-481-2917-1.

CANCER DE BEXIGA UROTELIAL; TRIAGEM HEMATURIA; URINA BASEADO MARCADORES TUMORAIS

189/465US=23-E / Câncer
Mowla SJ, Jafarnejad SM, Atlasi Y. Detection of OCT-4 in bladder cancer: role of cancer stem cell. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 211-26. ISBN 978-90-481-2917-1.

DETECCAO DE OCT-4; CANCER DE BEXIGA; PAPEL DE CELULA-TRONCO DO CANCER

190/465US=23-E / Câncer
Baker AC, Grizzle WE, Chhieng D. Uterine cervical glandular lesions: differentiation using immunohistochemistry of mucins. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 231-42. ISBN 978-90-481-2917-1.

CERVICO-UTERINO; LESOES GLANDULARES; IMUNOHISTOQUIMICA DAS MUCINAS

191/465US=23-E / Câncer
Baker AC, Grizzle WE, Chhieng D. Uterine cervical glandular lesions: differentiation using immunohistochemistry of mucins. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 243-53. ISBN 978-90-481-2917-1.

CERVICO-UTERINO; LESOES GLANDULARES; IMUNOHISTOQUIMICA DE MUCINAS

192/465US=23-E / Câncer
Kato S, Ohno T. Cancer imaging and intracavitary brachytherapy for cervical cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 257-62. ISBN 978-90-481-2917-1.

CANCER DE IMAGEM; BRAQUITERAPIA INTRACAVITARIA; CANCER CERVICAL

193/465US=23-E / Câncer
Greimel E. Cervical cancer: methods for assessing the quality of life. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 263-73. ISBN 978-90-481-2917-1.

CANCER DE COLO UTERINO; CANCER DE COLO UTERINO. QUALIDADE DE VIDA

194/465US=23-E / Câncer
Lin LL, Grigsby PW. Cervical cancer: positron emission tomography and positron emission tomography/computed tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 275-84. ISBN 978-90-481-2917-1.

CANCER CERVICAL; TOMOGRAFIA POR EMISSAO DE POSITRONS; TOMOGRAFIA POR EMISSAO DE POSITRONS/TOMOGRAFIA COMPUTADORIZADA

195/465US=23-E / Câncer
Ino K, Yamatomoto E, Shibata K, Kajiyama H, Nawa A, Kikkawa F. Cervical cancer: positron emission tomography and positron emission tomography/computed tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 275-84. ISBN 978-90-481-2917-1.

CANCER CERVICAL; TOMOGRAFIA POR EMISSAO DE POSITRONS; TOMOGRAFIA POR EMISSAO DE POSITRONS/TOMOGRAFIA COMPUTADORIZADA

196/465US=23-E / Câncer
Ino K, Yamatomoto E, Shibata K, Kajiyama H, Nawa A, Kikkawa F. Endometrial cancer: indoleamine 2,3-dioxygenase as a prognostic indicator. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 285-95. ISBN 978-90-481-2917-1.

CANCER DE ENDOMETRIO; 2,3-DIOXIGENASE INDOLEAMINA; INDICADOR DE PROGNOSTICO

197/465US=23-E / Câncer
Rübben A. Neurofibromatosis type 1-associated malignant melanoma: molecular evidence of inactivation of the NF1 gene. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 301-9. ISBN 978-90-481-2917-1.

NEUROFIBROMATOSE TIPO 1; MELANOMA MALIGNO; EVIDENCIA MOLECULAR DE INATIVACAO DO GENE NF1

198/465US=23-E / Câncer
Gheysens O, Mottaghy FM. Malignant melanoma: localisation and characterization using fluorodeoxyglucose-positron emission tomography/computed tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 311-22. ISBN 978-90-481-2917-1.

MELANOMA MALIGNO; FLUORODESOXIGLICOSE POR EMISSAO DE POSITRONS; TOMOGRAFIA COMPUTADORIZADA

199/465US=23-E / Câncer
Roesch A, Landthaler M, Vogt T. Malignant melanoma versus deep penetrating nevus:diagnostic and prognostic immunohistochemistry of dipeptidy1 peptidase IV (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 323-31. ISBN 978-90-481-2917-1.

MELANOMA MALIGNO; IMUNO-HISTOQUIMICA; DIPEPTIDE; PEPTIDASE IV; DIPEPTIDIL PEPTIDASE-4; DPP4

200/465US=23-E / Câncer
Hafner C. Nonmelanoma skin cancer use of Epha1 receptor as a prognostic marker. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 333-40. ISBN 978-90-481-2917-1.

CANCER DE PELE; EPHA1 RECEPTOR

Primeira | Anterior | Próxima | Última